Novo Nordisk's Q1 2025 results show a 19% sales increase, 20% operating income growth, and 14% net profit rise. Read why NVO ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

CEO Tara Comonte said the weight-loss program has no plans to shut down, and that its 3.4 million members would not be ...

While they share similarities, there are differences, particularly between the drugs semaglutide and tirzepatide.